Fractyl Health Inc. Commo... (GUTS)
NASDAQ: GUTS
· Real-Time Price · USD
1.03
0.05 (5.38%)
At close: Aug 15, 2025, 3:59 PM
1.03
-0.48%
After-hours: Aug 15, 2025, 07:52 PM EDT
Fractyl Health Common Stock Income Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q4 2021 | Q3 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Dec 31, 2021 | Sep 30, 2021 |
Revenue | n/a | n/a | 3K | 14K | 43K | 33K | 7K | 36K | 72K | 5K | n/a | n/a | n/a | n/a |
Cost of Revenue | 270K | 290K | -53K | 7K | 24K | 19K | 2K | 109K | 47K | 83K | 81K | n/a | 148K | 160K |
Gross Profit | -270K | -290K | 3K | 7K | 19K | 14K | 5K | -73K | 25K | -78K | -81K | n/a | -148K | -160K |
Operating Income | -26.08M | -24.76M | -25.21M | -23.79M | -22.98M | -21.54M | -12.98M | -13.87M | -11.88M | -12.11M | -11.41M | -11.55M | -11.97M | -8.78M |
Interest Income | 226K | 503K | 726K | 947K | 1.38M | 1.1M | 463K | 226K | 154K | 417K | 411K | 284K | n/a | n/a |
Pretax Income | -27.89M | -23.73M | -24.97M | -23.17M | -17.23M | -3.32M | -19.18M | -15.75M | -30.23M | -11.93M | -10.86M | -11.06M | -12.53M | -9.13M |
Net Income | -27.89M | -23.73M | -24.97M | -23.17M | -17.23M | -3.32M | -19.18M | -15.75M | -30.23M | -11.93M | -10.86M | -11.06M | -12.53M | -9.13M |
Selling & General & Admin | 4.66M | 5.32M | 4.93M | 4.8M | 6.24M | 7.08M | 2.78M | 4.42M | 2.76M | 2.68M | 2.71M | 3.02M | 4.01M | 2.25M |
Research & Development | 21.15M | 19.43M | 20.28M | 19M | 16.76M | 14.42M | 10.17M | 9.38M | 9.14M | 9.35M | 8.62M | 8.54M | 7.82M | 6.37M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 25.81M | 24.76M | 25.21M | 23.8M | 23M | 21.5M | 12.95M | 13.8M | 11.9M | 12.03M | 11.33M | 11.35M | 11.83M | 8.62M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 349K | 348K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.1M | n/a | n/a | n/a | -6.2M | n/a | n/a |
Cost & Expenses | 26.08M | 24.76M | 25.21M | 23.81M | 23.03M | 21.57M | 12.99M | 13.91M | 11.95M | 12.11M | 11.41M | 11.35M | 11.97M | 8.78M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 49.04M | 48.87M | 48.76M | 47.97M | 47.9M | 47.9M | 47.61M | 47.61M | 47.75M | 47.9M | 47.61M | 47.61M | 47.61M | 47.61M |
Shares Outstanding (Diluted) | 49.04M | 48.87M | 48.76M | 47.97M | 47.9M | 47.9M | 47.61M | 47.61M | 47.75M | 47.9M | 47.61M | 47.61M | 47.61M | 47.61M |
EPS (Basic) | -0.57 | -0.49 | -0.51 | -0.48 | -0.36 | -0.11 | -0.4 | -0.42 | -0.63 | -0.25 | -0.23 | -0.23 | -0.26 | -0.19 |
EPS (Diluted) | -0.57 | -0.49 | -0.51 | -0.48 | -0.36 | -0.11 | -0.4 | -0.42 | -0.63 | -0.25 | -0.23 | -0.23 | -0.26 | -0.19 |
EBITDA | -27.62M | -24.47M | -24.99M | -23.59M | -22.79M | -21.49M | -12.94M | -13.79M | -11.79M | -11.99M | -11.33M | -11.47M | -12.03M | -8.62M |
EBIT | -27.89M | -24.76M | -25.21M | -23.79M | -22.98M | -21.54M | -12.98M | -13.87M | -11.88M | -12.11M | -11.41M | -11.55M | -12.18M | -8.78M |
Depreciation & Amortization | 270K | 290K | 223K | 209K | 192K | 53K | 38K | 84K | 84K | 80K | 81K | 81K | 148K | 160K |